Latest news with #BoneMarrow
Time of India
25-04-2025
- Health
- Time of India
Chief Minister Bhupendra Patel inaugurates Gujarat's largest private cancer centre at HCG Aastha Cancer Centre, Ahmedabad
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG's commitment to accessible, world-class oncology in Gujarat In a noteworthy development for cancer care in Gujarat, Bhupendra Patel , the Chief Minister of Gujarat, inaugurated the expanded HCG Aastha Cancer Centre in its new premises opposite Bhagwat Vidyapith, Sola. Now the largest private comprehensive cancer care centre in the state, the inauguration was attended by HCG's senior leadership, Dr BS Ajaikumar, Raj Gore, Dr Bharat Gadhavi, and Sudharshan Bhamare, marking a significant leap forward in delivering accessible, world-class oncology care to the region. With increased capacity, next-generation technology, and a holistic care model, the upgraded facility reinforces HCG Aastha Cancer Centre Ahmedabad's commitment to delivering integrated, high-impact cancer treatment to patients across Gujarat and beyond. With a 217-bed capacity, a 140 per cent increase from its previous strength, the hospital is now equipped to handle significantly higher patient volumes with enhanced efficiency and personalised care. This includes 23 surgical ICU beds, 10 medical ICU beds, 23 daycare beds, 16 pre- and post-operative beds, and 6 Bone Marrow Transplant (BMT) units. This capacity boost will enable the hospital to manage a projected 30-40 per cent increase in patient footfall, translating to over 55,000 outpatient visits and 9,000 inpatient admissions annually. Backed by a multidisciplinary team of over 100 in-house doctors, the centre offers seamless, end-to-end care across surgical, medical, and radiation oncology, nuclear medicine, paediatric haemato-oncology, and advanced diagnostics. Speaking on the occasion, Bhupendra Patel, the Chief Minister of Gujarat, said, 'The launch of the HCG Aastha Cancer Centre in Ahmedabad is a significant step forward in making advanced cancer care more accessible. With its cutting-edge technology, the hospital provides excellent cancer treatment. The expertise of the hospital's highly experienced and dedicated team will significantly benefit the patients. I also applaud HCG for setting up a trust to support needy patients.' The Chief Minister highlighted the importance of healthy living, saying, 'Prime Minister Shri Narendra Modi has ensured the availability of comprehensive health initiatives—from yoga to Ayushman Bharat. Everyone should pay attention to their lifestyle to maintain good health.' Dr BS Ajaikumar, Executive Chairman, Healthcare Global Enterprises Limited, said, 'At HCG, our core philosophy has always been to deliver the right treatment the first time. We believe that quality cancer care should never be limited by geography. The expansion of HCG Aastha Cancer Centre in Ahmedabad is not merely an infrastructure milestone — it is a reaffirmation of our commitment to making advanced, evidence-based oncology accessible to every patient, no matter where they live. This centre brings together cutting-edge technology, organ-specific expertise, and a deeply compassionate care model, setting the benchmark for the future of cancer treatment. In this era of precision medicine, we are increasingly focused on leveraging genomics and proteomics to better understand tumour biology and guide personalised therapies. This approach enables us to improve outcomes, even in advanced and recurrent cases. With this facility, we strengthen our resolve to make high-quality cancer care more accessible, affordable, and outcome-driven — not just for Gujarat, but for all of India.' Raj Gore, CEO, Healthcare Global Enterprises Limited, added, 'The launch of the new premise with the upgraded facility at HCG Aastha Cancer Centre marks a strategic milestone in our ongoing mission to redefine cancer care in India. This facility not only reinforces our leadership in oncology but also aligns with our long-term vision to make world-class, technology and quality-driven cancer treatment more accessible. By integrating advanced modalities such as robotic-assisted surgeries with the expertise of our multidisciplinary teams, we aim to set new benchmarks in precision oncology and improve patient outcomes across the region.' Dr Bharat Gadhavi, Regional Director, HCG Group of Hospitals, Gujarat and Rajasthan , added, 'This state-of-the-art centre integrates cutting-edge clinical infrastructure, efficient processes, and a dedicated team to deliver more effective and personalised treatment. With this expansion, we are better equipped to offer patients the specialised care they need for improved outcomes. Since beginning its journey in Gujarat in 2007, HCG has established comprehensive cancer care facilities in Rajkot, Bhavnagar, and Vadodara. This new facility further strengthens our commitment to providing holistic cancer care under one roof, becoming a hub for managing complex and recurrent cases.' Sudharshan Bhamare, COO, HCG Astha Cancer Centre , Ahmedabad, added, 'This centre has been a conscious investment to meet the growing cancer care needs of Gujarat. From increasing bed strength to introducing specialised ICUs and surgical units, every aspect has been designed to handle more complex cases efficiently. This enhanced centre also enables us to reduce wait times, enhance patient comfort, and offer advanced treatments under one roof.' The centre continues to elevate its precision-led treatment approach through the integration of advanced technologies — including robotic surgery for GI, urological, and gynaecological cancers, Gujarat's first Tomo Therapy unit, and scalp cooling technology to help reduce chemotherapy-induced hair loss — a regional first. In addition to clinical upgrades, the expanded facility enhances its patient support ecosystem with services such as genetic counselling, multilingual international patient assistance, home and palliative care, and peer-led survivor support groups facilitated by the HCG Foundation and Ahmedabad Cancer Foundation. With this landmark expansion, HCG Aastha Cancer Centre, Ahmedabad, not only strengthens its leadership in oncology but also sets a new benchmark for patient-centric, compassionate innovation in cancer care for Gujarat and beyond. Disclaimer - The above content is non-editorial, and TIL hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content. Stay informed with the latest business news, updates on bank holidays and public holidays . Master Value & Valuation with ET! Learn to invest smartly & decode financials. Limited seats at 33% off – Enroll now!
Business Upturn
21-04-2025
- Health
- Business Upturn
HCG Aastha Cancer Centre expands operations in Ahmedabad with state's largest private oncology facility
HealthCare Global Enterprises Ltd (HCG) has officially inaugurated the expanded HCG Aastha Cancer Centre in Ahmedabad, Gujarat. The new facility, located opposite Bhagwat Vidyapith, Sola, now stands as the largest private comprehensive cancer care centre in the state. The inauguration was led by Shri Bhupendra Patel, Hon'ble Chief Minister of Gujarat, alongside HCG's leadership team including Dr. B.S. Ajaikumar, Mr. Raj Gore, Dr. Bharat Gadhavi, and Mr. Sudharshan Bhamare. Advertisement The upgraded facility features a 217-bed capacity, marking a 140% increase from its earlier capacity. This includes 23 surgical ICU beds, 10 medical ICU beds, 23 daycare beds, 16 pre- and post-operative beds, and 6 Bone Marrow Transplant (BMT) units. The expansion is designed to accommodate a projected 30–40% rise in patient volume, with an estimated 55,000 outpatient visits and 9,000 inpatient admissions annually. The cancer centre is supported by a multidisciplinary team of over 100 in-house doctors, delivering integrated services in surgical, medical, and radiation oncology, nuclear medicine, paediatric haemato-oncology, and advanced diagnostics. The facility incorporates advanced technologies such as robotic surgery for gastrointestinal, urological, and gynaecological cancers, Gujarat's first Tomo Therapy unit, and scalp cooling systems aimed at reducing hair loss during chemotherapy. In addition to clinical services, the centre also offers patient support features including genetic counselling, multilingual international patient assistance, home and palliative care, and survivor support groups. These are supported by the HCG Foundation and the Ahmedabad Cancer Foundation. The expansion of HCG Aastha Cancer Centre aims to improve access to high-quality cancer care for patients across Gujarat and surrounding regions.
Zawya
30-01-2025
- Health
- Zawya
Egypt's Health Ministry, Burjeel Holdings collaborate to develop advanced BMT program and elevate Oncology care
Dubai, UAE: In a significant step towards strengthening healthcare collaboration, the Ministry of Health, Egypt and Burjeel Holdings, a leading super-specialty healthcare services provider in the MENA region, have signed a Memorandum of Understanding (MoU) at Arab Health 2025. The agreement paves the way for a strategic partnership aimed at expanding access to advanced oncology care across Africa, with a particular focus on developing a comprehensive Bone Marrow Transplant (BMT) Program. This initiative will be spearheaded by Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, supported by Burjeel Cancer Institute, the largest integrated cancer care network in the UAE. The agreement was signed by Dr. Maha Ibrahim, Head of the Secretariat of Specialized Medical Centers, Ministry of Health, Egypt, and Mr. John Sunil, Group CEO of Burjeel Holdings, in the presence of H.E. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population of Egypt, Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, Mr. Omran Al Khoori, Member of the Board of Directors, Burjeel Holdings, and Mr. Safeer Ahamed, Group Co-CEO, Burjeel Holdings. Focus on Bone Marrow Transplants As part of the commitment to improving patient outcomes, the collaboration will develop a dedicated strategy to address and reduce the backlog of BMT patients in Egypt, ensuring timely access to life-saving procedures. Under this initiative, Burjeel Holdings will leverage its expertise from its highly successful BMT program at BMC to establish a world-class transplant unit in Egypt. The program will integrate proven protocols, advanced treatment methodologies, and multidisciplinary clinical approaches to enhance patient care and improve transplant success rates. Comprehensive training for adult and pediatric BMT programs will be provided, empowering physicians, nurses, lab technicians, and supporting services in Egypt. The training will include hands-on experience in cutting-edge transplant techniques, post-transplant care, and multidisciplinary patient management, ensuring that local medical professionals are equipped with the latest advancements in BMT care. Furthermore, the MoU paves the way for a research partnership between the Health Ministry and BMC, focusing on pioneering cancer treatments such as CAR-T cell therapy to advance Egypt's capabilities in next-generation oncology solutions and innovative therapies. Speaking on the occasion, H.E. Khaled Abdel Ghaffar stated, 'This partnership with Burjeel Holdings underscores our commitment to enhancing healthcare accessibility and innovation in Egypt. By leveraging their expertise in oncology care, BMT program, and medical training, we aim to bring the highest standards of cancer treatment to our patients.' Oncology Nursing Training, Technology Integration In addition to BMT training, the partnership will extend specialized training to radiation oncology staff on advanced techniques, including stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) using the cutting-edge BrainLab system. To enhance diagnostic and precision medicine capabilities, staff will also receive training in molecular lab techniques, molecular pathology, and digital pathology, in collaboration with OncoHelix. A one-year specialized oncology nursing training program will be launched, further strengthening the expertise of healthcare professionals in Egypt and the region. The initiative will also support the recruitment of oncology-trained nurses and facilitate authority accreditation, reinforcing long-term collaboration in cancer care. Dr. Shamsheer Vayalil said, 'We are honored to collaborate with the Ministry of Health, Egypt, in driving transformative changes in oncology care. Through strategic initiatives in training, research, and patient access, we look forward to making a meaningful impact in cancer treatment in Egypt.' Additionally, a medical tourism framework will be established between the Ministry, designated agents, and BMC to enhance oncology care accessibility for patients across Africa. This initiative aligns with Egypt's healthcare transformation goals, ensuring sustainable growth, stronger partnerships, and expanded access to specialized oncology care. The agreement marks a significant milestone in Egypt's healthcare advancement. By integrating expertise, cutting-edge technology, and world-class training programs, this collaboration between the Ministry of Health and Burjeel Holdings is set to redefine cancer care in the region.
